Trader consensus on Polymarket reflects a 93% implied probability for no new coronavirus pandemic in 2026, driven by robust global surveillance from WHO and CDC revealing no confirmed outbreaks of novel coronaviruses beyond ongoing SARS-CoV-2 variants. As of early April 2026, acute respiratory illness remains low, with CDC data showing COVID-19 infections declining or stable across U.S. states and no escalation to epidemic thresholds; the emerging BA.3.2 ("Cicada") variant, despite immune escape potential and detection in 29 states, causes mild symptoms akin to prior strains amid widespread immunity from vaccines and prior infections. Key resolution hinges on WHO pandemic declaration criteria, absent amid moderate public health risk assessments. Realistic challenges include undetected zoonotic spillovers or lab incidents sparking rapid global transmission, with upcoming genomic surveillance updates potentially influencing sentiment.